Evidence map›Paper›PMID 8058773›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1994

Intrinsic 5-lipoxygenase activity is required for neutrophil responsivity.

D M Guidot, M J Repine, J Y Westcott, J E Repine

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Functional genomic assessment of phosgene-induced acute lung injury in mice.American journal of respiratory cell and molecular biology · 2013
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

D M GuidotWebb-Waring Institute for Biomedical Research, University of Colorado Health Sciences Center, Denver 80262.
M J Repine
J Y Westcott
J E Repine
University of Colorado Health · US

Funding

MITOCHONDRIAL SUPEROXIDE GENERATION IN HYPEROXIAK11HL002690 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI GUIDOT, DAVID MARSHALL · 1992 to 1996
–
TYPE II CELLS AND INTERSTITIAL LUNG DISEASEP50HL027353 · NHLBI · NATIONAL JEWISH HEALTH · 1985 to 1996
–
NHLBI NIH HHS K11-HL02690NHLBI NIH HHS P50-HL27353PHS HHS R0 1-45582
6 · The paper itself

Abstract

We found that intrinsic neutrophil 5-lipoxygenase activity was necessary for human neutrophil adherence and chemotaxis in vitro and human neutrophil-mediated acute edematous injury in isolated perfused rat lungs given interleukin 8 intratracheally. Treatment with either Zileuton (a specific reversible competitive inhibitor of 5-lipoxygenase) or MK886 (a specific irreversible inhibitor of the 5-lipoxygenase activator protein) prevented stimulated neutrophil adherence and chemotaxis (but not superoxide anion production) in vitro. Zileuton- or MK886-inhibited neutrophil chemotaxis was not restored by adding leukotriene B4 in vitro. Perfusion with neutrophils and either Zileuton or MK886, or with MK886-pretreated neutrophils (without adding MK886 to the perfusate), also prevented lung injury (reflected by lung weight gain and lung Ficoll retention) and perfusate leukotriene B4 increases in isolated rat lungs given interleukin 8 intratracheally. Again, adding leukotriene B4 to the perfusate did not damage interleukin 8-treated isolated lungs perfused with Zileuton-inhibited neutrophils. We conclude that intrinsic 5-lipoxygenase activity is required for neutrophil adherence and chemotaxis and neutrophil-mediated lung injury.

Indexed as

Chemotaxis, LeukocyteAnimalsArachidonate 5-LipoxygenaseCell AdhesionChlorobenzenesCytochrome c GroupDose-Response Relationship, DrugHumansHydroxyureaIndolesInterleukin-8In Vitro TechniquesKineticsLeukotriene AntagonistsLeukotriene B4Lipoxygenase InhibitorsArachidonate 5-LipoxygenaseChlorobenzenesCytochrome c GroupHydroxyureaIndolesInterleukin-8Leukotriene AntagonistsLeukotriene B4Lipoxygenase InhibitorsMK-886Recombinant ProteinsSuperoxidesTetradecanoylphorbol Acetatezileuton

Identifiers

PMID8058773
PMCPMC44564
OpenAlexW2016216187

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.